Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies (2022)
Source: Future Medicinal Chemistry. Unidade: IFSC
Subjects: FÁRMACOS, PLANEJAMENTO DE FÁRMACOS, DOENÇAS PARASITÁRIAS, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Aldo Sena de et al. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies. Future Medicinal Chemistry, v. 14, n. 11, p. 795-808, 2022Tradução . . Disponível em: https://doi.org/10.4155/fmc-2022-0013. Acesso em: 20 ago. 2024.APA
Oliveira, A. S. de, Valli, M., Ferreira, L. L. G., Souza, J. M., Andricopulo, R. K., Meier, L., et al. (2022). Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies. Future Medicinal Chemistry, 14( 11), 795-808. doi:10.4155/fmc-2022-0013NLM
Oliveira AS de, Valli M, Ferreira LLG, Souza JM, Andricopulo RK, Meier L, Abreu HR, Voltolini BG, Llanes LC, Nunes RJ, Braga AL, Andricopulo AD. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies [Internet]. Future Medicinal Chemistry. 2022 ; 14( 11): 795-808.[citado 2024 ago. 20 ] Available from: https://doi.org/10.4155/fmc-2022-0013Vancouver
Oliveira AS de, Valli M, Ferreira LLG, Souza JM, Andricopulo RK, Meier L, Abreu HR, Voltolini BG, Llanes LC, Nunes RJ, Braga AL, Andricopulo AD. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies [Internet]. Future Medicinal Chemistry. 2022 ; 14( 11): 795-808.[citado 2024 ago. 20 ] Available from: https://doi.org/10.4155/fmc-2022-0013